切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Flk1 - c-MET - 5-HT receptor

12件产品中的 1-10

页面
每页
清除全部
  1. Altiratinib
    B5832 Altiratinib
     1 Citation
    Target: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2
    Summary: c-MET/TIE-2/VEGFR抑制剂
      ≥21.55 mg/mL
      insoluble in H2O
  2. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
    中文名: 米哚妥林
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC抑制剂
      ≥57.1 mg/mL
      insoluble in H2O
  3. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  4. INCB28060
    A8448 INCB28060
    中文名: 苯扎米特
    Target: c-MET
    Summary: C-Met抑制剂
      ≥5.15 mg/mL
      insoluble in H2O
  5. MGCD-265
    A5057 MGCD-265
    Target: VEGFR|c-MET
    Summary: Met/Flt/Flk/Ron/Tie-2抑制剂
      ≥25.9 mg/mL
      insoluble in H2O
  6. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    中文名: 布立尼布
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2的ATP竞争性抑制剂
      ≥18.5 mg/mL
      insoluble in H2O
  7. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: 有效的HER2选择性抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  8. PF-04217903
    A5096 PF-04217903
    Target: c-MET
    Summary: C-Met的选择性和ATP竞争性抑制剂
      ≥18.6 mg/mL
      insoluble in H2O
  9. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: c-Met的ATP竞争性、有效的、选择性抑制剂
      ≥32.1 mg/mL
      insoluble in H2O
  10. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页